Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants

Nature Communications

Volumn 8, Issue , 2017, Pages

  Tsoi, Lam C ^a,b   Stuart, Philip E ^a   Tian, Chao ^c   Gudjonsson, Johann E ^a   Das, Sayantan ^b   Zawistowski, Matthew ^b   Ellinghaus, Eva ^d   Barker, Jonathan N ^e   Chandran, Vinod ^f,g   Dand, Nick ^e   Duffin, Kristina Callis ^h   Enerbäck, Charlotta ⁱ   Esko, Tõnu ^j,k   Franke, Andre ^d   Gladman, Dafna D ^f,g   Hoffmann, Per ^l,m   Kingo, Külli ⁿ   Kõks, Sulev ^o,p   Krueger, Gerald G ^h   Lim, Henry W ^q   Metspalu, Andres ^j   Mrowietz, Ulrich ^r   Mucha, Sören ^d   Rahman, Proton ^s   Reis, Andre ^t   Tejasvi, Trilokraj ^t   Trembath, Richard ^v   Voorhees, John J ^a   Weidinger, Stephan ^r   Weichenthal, Michael ^r   Wen, Xiaoquan ^b   Eriksson, Nicholas ^c   Kang, Hyun M ^b   Hinds, David A ^c   Nair, Rajan P ^a   Abecasis, Gonçalo R ^b   Elder, James T ^a,u   more..

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c 23andMe Inc ^*  (United States)

^d UNIVERSITY OF KIEL   (Germany)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ LINKÖPING UNIVERSITY   (Sweden)

^j UNIVERSITY OF TARTU   (Estonia)

^k BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^l UNIVERSITY OF BONN   (Germany)

^m UNIVERSITY OF BASEL   (Switzerland)

ⁿ TARTU UNIVERSITY HOSPITAL   (Estonia)

^o UNIVERSITY OF TARTU   (Estonia)

^p ESTONIAN UNIVERSITY OF LIFE SCIENCES   (Estonia)

^q HENRY FORD HOSPITAL   (United States)

^r UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^s MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^t UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^u VETERANS AFFAIRS MEDICAL CENTER   (United States)

^v KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON;

CELLS AND CELL COMPONENTS; DISEASE INCIDENCE; GENETIC ANALYSIS; GENOME; HERITABILITY; META-ANALYSIS; PROTEIN; SKIN; SKIN DISORDER;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; GENE LOCUS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HERITABILITY; HUMAN; PSORIASIS; TH0 CELL; TH1 CELL; TH17 CELL; CAUCASIAN; GENE REGULATORY NETWORK; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; META ANALYSIS; METABOLISM; ONSET AGE; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

EUROPE;

AGE OF ONSET; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE REGULATORY NETWORKS; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERFERONS; NF-KAPPA B; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN INTERACTION MAPS; PSORIASIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 85019965749     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms15382     Document Type: Article

References (51)

1. Lowes, M. A., Suarez-Farinas, M. & Krueger, J. G. Immunology of psoriasis. Annu. Rev. Immunol. 32, 227-255 (2014).
2. Chandran, V. & Raychaudhuri, S. P. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J. Autoimmun. 34, J314-J321 (2010).
3. Yin, X. et al. Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat. Commun. 6, 6916 (2015).
4. Zuo, X. et al. Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis. Nat. Commun. 6, 6793 (2015).
5. Ellinghaus, E. et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat. Genet. 42, 991-995 (2010).
6. Nair, R. P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 41, 199-204 (2009).
7. Strange, A. et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42, 985-990 (2010).
8. Stuart, P. E. et al. Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat. Genet. 42, 1000-1004 (2010).
9. Tsoi, L. C. et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44, 1341-1348 (2012).
10. Sun, L. D. et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat. Genet. 42, 1005-1009 (2010).
11. Li, Y. et al. Association analyses identifying two common susceptibility loci shared by psoriasis and systemic lupus erythematosus in the Chinese Han population. J. Med. Genet. 50, 812-818 (2013).
12. Sheng, Y. et al. Sequencing-based approach identified three new susceptibility loci for psoriasis. Nat. Commun. 5, 4331 (2014).
13. Tang, H. et al. A large-scale screen for coding variants predisposing to psoriasis. Nat. Genet. 46, 45-50 (2014).
14. Zhang, X. J. et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat. Genet. 41, 205-210 (2009).
15. Ellinghaus, D. et al. Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci. Am. J. Hum. Genet. 90, 636-647 (2012).
16. Bowes, J. et al. Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nat. Commun. 6, 6046 (2015).
17. Tsoi, L. C. et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nat. Commun. 6, 7001 (2015).
18. Stuart, P. E. et al. Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. Am. J. Hum. Genet. 97, 816-836 (2015).
19. Gudjonsson, J. E. & Elder, J. T. in Dermatology in General Medicine, Vol. 1 (ed. Goldsmith, L. et al.), 197-231 (McGraw-Hill, 2012).
20. Harden, J. L., Krueger, J. G. & Bowcock, A. M. The immunogenetics of Psoriasis: a comprehensive review. J. Autoimmun. 64, 66-73 (2015).
21. Delaneau, O., Marchini, J. & Zagury, J. F. A linear complexity phasing method for thousands of genomes. Nat. Methods 9, 179-181 (2012).
22. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955-959 (2012).
23. 1000 Genomes Project Consortium et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56-65 (2012).
24. Duffy, S. W. et al. A simple model for potential use with a misclassified binary outcome in epidemiology. J. Epidemiol. Community Health 58, 712-717 (2004).
25. Albert, P. S., Liu, A. & Nansel, T. Efficient logistic regression designs under an imperfect population identifier. Biometrics 70, 175-184 (2014).
26. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010).
27. Han, B. & Eskin, E. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am. J. Hum. Genet. 88, 586-598 (2011).
28. Cortes, A. & Brown, M. A. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 13, 101 (2011).
29. Park, J. H. et al. Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. Proc. Natl Acad. Sci. USA 108, 18026-18031 (2011).
30. Grjibovski, A. M., Olsen, A. O., Magnus, P. & Harris, J. R. Psoriasis in Norwegian twins: contribution of genetic and environmental effects. J. Eur. Acad. Dermatol. Venereol. 21, 1337-1343 (2007).
31. So, H. C., Gui, A. H., Cherny, S. S. & Sham, P. C. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet. Epidemiol. 35, 310-317 (2011).
32. Gladman, D. D., Antoni, C., Mease, P., Clegg, D. O. & Nash, P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann. Rheum. Dis. 64, ii14-ii17 (2005).
33. Henseler, T. & Christophers, E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J. Am. Acad. Dermatol. 13, 450-456 (1985).
34. Queiro, R., Tejon, P., Alonso, S. & Coto, P. Age at disease onset: a key factor for understanding psoriatic disease. Rheumatology 53, 1178-1185 (2014).
35. Tsoi, L. C., Elder, J. T. & Abecasis, G. R. Graphical algorithm for integration of genetic and biological data: proof of principle using psoriasis as a model. Bioinformatics 31, 1243-1249 (2015).
36. Farh, K. K. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337-343 (2015).
37. Lin, Y. et al. Identification of cell types, tissues and pathways affected by risk loci in psoriasis. Mol. Genet. Genomics 291, 1005-1012 (2016).
38. Aterido, A. et al. Genome-wide pathway analysis identifies genetic pathways associated with Psoriasis. J. Invest. Dermatol. 136, 593-602 (2016).
39. Law, V. et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091-D1097 (2014).
40. Whirl-Carrillo, M. et al. Pharmacogenomics knowledge for personalized medicine. Clin. Pharmacol. Ther. 92, 414-417 (2012).
41. Cortes-Franco, R., Fernandez, L. M. & Dominguez-Soto, L. Psoriasis treatment with 5-aminosalicylic acid. Int. J. Dermatol. 33, 573-575 (1994).
42. Bharti, R. Mesalazine in treatment of psoriasis. Indian J. Dermatol. Venereol. Leprol. 62, 231-232 (1996).
43. Gupta, A. K. et al. Sulfasalazine improves psoriasis. A double-blind analysis. Arch. Dermatol. 126, 487-493 (1990).
44. Denny, J. C. et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat. Biotechnol. 31, 1102-1110 (2013).
45. Yin, X. et al. A weighted polygenic risk score using 14 known susceptibility variants to estimate risk and age onset of psoriasis in Han Chinese. PLoS ONE 10, e0125369 (2015).
46. Chen, H. et al. A genetic risk score combining ten psoriasis risk loci improves disease prediction. PLoS ONE 6, e19454 (2011).
47. Gudjonsson, J. E. et al. Distinct clinical differences between HLA-Cw0602 positive and negative psoriasis patients-an analysis of 1019 HLA-C-and HLA-B-typed patients. J. Invest. Dermatol. 126, 740-745 (2006).
48. Scherr, R., Essers, J., Hakonarson, H. & Kugathasan, S. Genetic determinants of pediatric inflammatory bowel disease: is age of onset genetically determined? Dig. Dis. 27, 236-239 (2009).
49. Sorosina, M. et al. Inverse correlation of genetic risk score with age at onset in bout-onset and progressive-onset multiple sclerosis. Mult. Scler. 21, 1463-1467 (2014).
50. Parisi, R., Symmons, D. P., Griffiths, C. E. & Ashcroft, D. M. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J. Invest. Dermatol. 133, 377-385 (2012).
51. Chatr-Aryamontri, A. et al. The BioGRID interaction database: 2015 update. Nucleic Acids Res. 43, D470-D478 (2015).